Skip to Content

WATSON 796 (Sulfasalazine 500 mg)

Pill with imprint WATSON 796 is Yellow, Round and has been identified as Sulfasalazine 500 mg. It is supplied by Watson Pharmaceuticals.

Sulfasalazine is used in the treatment of juvenile rheumatoid arthritis; inflammatory bowel disease; lymphocytic colitis; rheumatoid arthritis; ulcerative colitis and belongs to the drug classes 5-aminosalicylates, antirheumatics. There is no proven risk in humans during pregnancy. Sulfasalazine 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 796

Sulfasalazine 500 mg WATSON 796
Sulfasalazine 500 mg WATSON 796  Front
Sulfasalazine 500 mg WATSON 796  Back
Sulfasalazine 500 mg WATSON 796

Sulfasalazine

Imprint
WATSON 796
Strength
500 mg
Color
Yellow
Size
13.00 mm
Shape
Round
Availability
Prescription only
Drug Class
5-aminosalicylates, Antirheumatics
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00591-0796
Inactive Ingredients
magnesium stearate, corn starch, stearic acid, sodium starch glycolate type A potato

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.